Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3464)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$566.42
Total Value
$90.63K
Shares Held After
40,513
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,259
Price
$566.02
Total Value
$1.28M
Shares Held After
40,673
% of Holdings
5.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,840
Price
$564.87
Total Value
$1.04M
Shares Held After
42,932
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,242
Price
$563.77
Total Value
$1.26M
Shares Held After
44,772
% of Holdings
4.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,760
Price
$562.98
Total Value
$990.84K
Shares Held After
47,014
% of Holdings
3.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
919
Price
$561.97
Total Value
$516.45K
Shares Held After
48,774
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$560.03
Total Value
$156.81K
Shares Held After
49,693
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$557.85
Total Value
$22.31K
Shares Held After
49,973
% of Holdings
0.1%
Oruka Therapeutics, Inc. (ORKA)
Dambkowski Carl — Director
Shares
13,235
Price
$59.97
Total Value
$793.66K
Shares Held After
73,743
% of Holdings
15.2%
Oruka Therapeutics, Inc. (ORKA)
Dambkowski Carl — Director
Shares
53,447
Price
$59.10
Total Value
$3.16M
Shares Held After
86,978
% of Holdings
38.1%
Oruka Therapeutics, Inc. (ORKA)
Dambkowski Carl — Director
Shares
38,318
Price
$58.43
Total Value
$2.24M
Shares Held After
140,425
% of Holdings
21.4%
Monte Rosa Therapeutics, Inc. (GLUE)
Manning Anthony M. — Director
Shares
10,000
Price
$18.01
Total Value
$180.10K
Shares Held After
0
% of Holdings
100.0%
Kura Oncology, Inc. (KURA)
Powl Brian T. — Chief Commercial Officer
Shares
10,000
Price
$11.00
Total Value
$110.00K
Shares Held After
173,614
% of Holdings
5.4%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
14,028
Price
$6.27
Total Value
$87.92K
Shares Held After
1,720,033
% of Holdings
0.8%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
17,926
Price
$6.27
Total Value
$112.35K
Shares Held After
1,734,061
% of Holdings
1.0%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
7,861
Price
$6.27
Total Value
$49.27K
Shares Held After
1,751,987
% of Holdings
0.4%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
14,933
Price
$6.27
Total Value
$93.59K
Shares Held After
1,759,848
% of Holdings
0.8%
ARDELYX, INC. (ARDX)
Williams Laura A — Chief Patient Officer
Shares
1,418
Price
$6.27
Total Value
$8.89K
Shares Held After
429,093
% of Holdings
0.3%
ARDELYX, INC. (ARDX)
Williams Laura A — Chief Patient Officer
Shares
1,911
Price
$6.27
Total Value
$11.98K
Shares Held After
430,511
% of Holdings
0.4%
ARDELYX, INC. (ARDX)
Williams Laura A — Chief Patient Officer
Shares
2,157
Price
$6.27
Total Value
$13.52K
Shares Held After
432,422
% of Holdings
0.5%
ARDELYX, INC. (ARDX)
Williams Laura A — Chief Patient Officer
Shares
1,503
Price
$6.27
Total Value
$9.42K
Shares Held After
434,579
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
300
Price
$562.50
Total Value
$168.75K
Shares Held After
45,172
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
270
Price
$566.05
Total Value
$152.83K
Shares Held After
45,472
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,251
Price
$565.20
Total Value
$707.06K
Shares Held After
45,742
% of Holdings
2.7%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
2,015
Price
$564.06
Total Value
$1.14M
Shares Held After
46,993
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
1,326
Price
$562.93
Total Value
$746.45K
Shares Held After
49,008
% of Holdings
2.6%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
2,178
Price
$561.99
Total Value
$1.22M
Shares Held After
50,334
% of Holdings
4.1%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
200
Price
$559.99
Total Value
$112.00K
Shares Held After
52,512
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
640
Price
$557.85
Total Value
$357.02K
Shares Held After
52,712
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
10
Price
$556.70
Total Value
$5.57K
Shares Held After
53,352
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
MAHON PAUL A — EVP & GENERAL COUNSEL
Shares
110
Price
$555.72
Total Value
$61.13K
Shares Held After
53,362
% of Holdings
0.2%
Kalaris Therapeutics, Inc. (KLRS)
AKKARAJU SRINIVAS — Director
Shares
244,300
Price
$4.83
Total Value
$1.18M
Shares Held After
2,224,147
% of Holdings
11.0%
BioXcel Therapeutics, Inc. (BTAI)
Mehta Vimal — Director
Shares
19,419
Price
$1.09
Total Value
$21.11K
Shares Held After
69,598
% of Holdings
21.8%
BioXcel Therapeutics, Inc. (BTAI)
Rodriguez Javier — Chief Legal Officer, Senior Vice President and Corporate Secretary
Shares
6,560
Price
$1.08
Total Value
$7.11K
Shares Held After
26,803
% of Holdings
19.7%
BioXcel Therapeutics, Inc. (BTAI)
Yocca Frank — Chief Scientific Officer
Shares
6,845
Price
$1.08
Total Value
$7.43K
Shares Held After
26,175
% of Holdings
20.7%
BioXcel Therapeutics, Inc. (BTAI)
Steinhart Richard I — Chief Financial Officer
Shares
6,845
Price
$1.08
Total Value
$7.43K
Shares Held After
26,300
% of Holdings
20.7%
GYRE THERAPEUTICS, INC. (GYRE)
Ye Weiguo — Chief Operating Officer
Shares
9,400
Price
$6.15
Total Value
$57.81K
Shares Held After
700,000
% of Holdings
1.3%
Dyne Therapeutics, Inc. (DYN)
Posner Brian S — Director
Shares
2,500
Price
$17.12
Total Value
$42.80K
Shares Held After
18,000
% of Holdings
13.9%
EXELIXIS, INC. (EXEL)
Haley Patrick J. — EVP, Commercial
Shares
32,110
Price
$49.81
Total Value
$1.60M
Shares Held After
357,638
% of Holdings
8.2%
VERACYTE, INC. (VCYT)
EPSTEIN ROBERT S — Director
Shares
10,000
Price
$44.01
Total Value
$440.13K
Shares Held After
52,446
% of Holdings
16.0%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
1,698
Price
$32.95
Total Value
$55.95K
Shares Held After
242,107
% of Holdings
0.7%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
1,168
Price
$32.15
Total Value
$37.55K
Shares Held After
243,805
% of Holdings
0.5%
Immunovant, Inc. (IMVT)
Gloria Melanie — Chief Operating Officer
Shares
249
Price
$30.41
Total Value
$7.57K
Shares Held After
244,973
% of Holdings
0.1%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
48
Price
$111.89
Total Value
$5.37K
Shares Held After
0
% of Holdings
100.0%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
891
Price
$111.30
Total Value
$99.17K
Shares Held After
48
% of Holdings
94.9%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
3,363
Price
$110.35
Total Value
$371.09K
Shares Held After
939
% of Holdings
78.2%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
1,563
Price
$64.43
Total Value
$100.71K
Shares Held After
490,000
% of Holdings
0.3%
Pharvaris N.V. (PHVS)
Bjork Elisabeth — Director
Shares
10,000
Price
$29.32
Total Value
$293.17K
Shares Held After
15,167
% of Holdings
39.7%
Royalty Pharma plc (RPRX)
Urist Marshall — EVP, Research & Investments
Shares
13,684
Price
$52.75
Total Value
$721.84K
Shares Held After
18,197
% of Holdings
42.9%
Annovis Bio, Inc. (ANVS)
Hoffman Michael B — Director
Shares
54,933
Price
$1.90
Total Value
$104.37K
Shares Held After
3,364,883
% of Holdings
1.6%
Showing 301–350 of 3464 transactions (page 7 of 70)